Clinical Utility of Bronchoalveolar Lavage in Pediatric Oncology Patients.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
28
7
2022
medline:
15
10
2022
entrez:
27
7
2022
Statut:
ppublish
Résumé
Lower airway sampling is important in the assessment of lower respiratory tract infection in children with cancer or posthematopoietic stem cell transplant and can be done via bronchoalveolar lavage (BAL). Clinicians can struggle with balancing the benefits of BAL against the risks. This study aimed to define the diagnostic and clinical utility of BAL in this population. A single-center retrospective review of BAL performed in children with cancer or posthematopoietic stem cell transplant. Data extracted included demographics, BAL method and results and antimicrobial treatment. Variables significantly associated with diagnostic yield, diagnostic impact (confirmation or exclusion of infection), and clinical impact (any change in antimicrobial or nonantimicrobial therapy) were assessed in both univariate and multivariate analysis. Seventy-three BAL episodes were included. In 26 (35.6%) episodes, a pathogen was identified on BAL. Forty-nine (67%) BAL episodes had a diagnostic impact and 15 (21%) had a clinical impact. Late BAL (>72 hours) compared with early BAL (odds ratio 3.27; 95% CI: 1.03-10.86), and flexible bronchoscopy compared with nonbronchoscopic lavage (odds ratio 6.10; 95% CI: 1.90-24.0), were more likely to have a diagnostic impact on multivariate analysis. No associations were found for clinical impact. One-third of BAL episodes identified a pathogen, two-thirds had a diagnostic impact, and almost a quarter of episodes impacted antimicrobial prescribing. The method and timing of BAL may be important, with flexible bronchoscopy 6-fold more likely and late BAL 3-fold more likely to have a diagnostic impact.
Sections du résumé
BACKGROUND
Lower airway sampling is important in the assessment of lower respiratory tract infection in children with cancer or posthematopoietic stem cell transplant and can be done via bronchoalveolar lavage (BAL). Clinicians can struggle with balancing the benefits of BAL against the risks. This study aimed to define the diagnostic and clinical utility of BAL in this population.
METHODS
A single-center retrospective review of BAL performed in children with cancer or posthematopoietic stem cell transplant. Data extracted included demographics, BAL method and results and antimicrobial treatment. Variables significantly associated with diagnostic yield, diagnostic impact (confirmation or exclusion of infection), and clinical impact (any change in antimicrobial or nonantimicrobial therapy) were assessed in both univariate and multivariate analysis.
RESULTS
Seventy-three BAL episodes were included. In 26 (35.6%) episodes, a pathogen was identified on BAL. Forty-nine (67%) BAL episodes had a diagnostic impact and 15 (21%) had a clinical impact. Late BAL (>72 hours) compared with early BAL (odds ratio 3.27; 95% CI: 1.03-10.86), and flexible bronchoscopy compared with nonbronchoscopic lavage (odds ratio 6.10; 95% CI: 1.90-24.0), were more likely to have a diagnostic impact on multivariate analysis. No associations were found for clinical impact.
CONCLUSIONS
One-third of BAL episodes identified a pathogen, two-thirds had a diagnostic impact, and almost a quarter of episodes impacted antimicrobial prescribing. The method and timing of BAL may be important, with flexible bronchoscopy 6-fold more likely and late BAL 3-fold more likely to have a diagnostic impact.
Identifiants
pubmed: 35895881
doi: 10.1097/INF.0000000000003648
pii: 00006454-990000000-00139
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
899-903Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Elbahlawan L, Rains KJ, Stokes DC. Respiratory care considerations in the childhood cancer patient. Respir Care. 2017;62:765–775.
Rizik S, Hakim F, Bentur L, et al. Bronchoscopy and bronchoalveolar lavage in the diagnosis and management of pulmonary infections in immunocompromised children. J Pediatr Hematol Oncol. 2018;40:532–535.
Batra S, Li B, Underhill N, et al. Clinical utility of bronchoalveolar lavage and respiratory tract biopsies in diagnosis and management of suspected invasive respiratory fungal infections in children. Pediatr Blood Cancer. 2015;62:1579–1586.
Gonski K, Cohn R, Widger J, et al. Utility of bronchoscopy in immunocompromised paediatric patients: systematic review. Paediatr Respir Rev. 2020;34:24–34.
Riedler J, Grigg J, Robertson CF. Role of bronchoalveolar lavage in children with lung disease. Eur Respir J. 1995;8:1725–1730.
Royal Children’s Hospital. Antifungal prophylaxis for children with cancer or undergoing haematopoietic stem cell transplant. 2021. Available at: https://www.rch.org.au/clinicalguide/guideline_index/Antifungal_prophylaxis_for_children_with_cancer_or_undergoing_haematopoietic_stem_cell_transplant/ . Accessed February 1, 2022.
Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines†. Ann Oncol. 2016;27:v111v118.
Nadimpalli S, Foca M, Satwani P, et al. Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders. Pediatr Pulmonol. 2017;52:820–826.
Lucena CM, Torres A, Rovira M, et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014;49:1293–1299.
Kotby AA, Shaheen MA, Basim HH, et al. Diagnostic Bronchoalveolar Lavage (BAL) for pulmonary fungal infections in critically ill children. J Bronchol Interv Pulmonol. 2008;15:410.
Dubourg G, Abat C, Rolain JM, et al. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol. 2015;53:994–996.
Ronchetti K, Tame JD, Paisey C, et al. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial. Lancet Respir Med. 2018;6:461–471.
Furuya ME, Ramírez-Figueroa JL, Vargas MH, et al. Diagnoses unveiled by early bronchoscopy in children with leukemia and pulmonary infiltrates. J Pediatr Hematol Oncol. 2012;34:596–600.
Elbahlawan LM, Avent Y, Montoya L, et al. Safety and benefits of bronchoalveolar lavage and lung biopsy in the management of pulmonary infiltrates in children with leukemia. J Pediatr Hematol Oncol. 2016;38:597–601.
Seneviratna A, O’Carroll M, Lewis CA, et al. Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders. Intern Med J. 2012;42:536–541.
Kasow KA, King E, Rochester R, et al. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002. Biol Blood Marrow Transplant. 2007;13:831–837.
Koltsida G, Zaoutis T. Fungal lung disease. Paediatr Respir Rev. 2021;37:99–104.
Rossoff J, Locke M, Helenowski IB, et al. Cost analysis of bronchoalveolar lavage and respiratory tract biopsies in the diagnosis and management of suspected invasive fungal infection in children with cancer or who have undergone stem cell transplant. Pediatr Blood Cancer. 2019;66:e27598.